ORIGINAL ARTICLES

Presentation and management of orbito-ocular malignancies in a tertiary institution in Southwest Nigeria

Adewumi Olabimpe Alabi¹, Adegboyega Sunday Alabi², Anthonia Chima Sowunmi¹, Kehinde O Ololade¹, Bolanle Comfort Adegboyega³, Muhammad Yaqub M Habeebu¹, Omolara Amina Fatiregun³, Folasade Bolanle Akinsola²

¹ Department of Radiation Biology, Radio-diagnosis and Radiotherapy, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria
² Department of Ophthalmology, College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria
³ Department of Radiotherapy, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria

Correspondence Address:
Dr. Adewumi Olabimpe Alabi
Department of Radiation Biology, Radio-diagnosis and Radiotherapy, College of Medicine, University of Lagos, Idi-araba, Lagos Nigeria

Source of Support: None
Conflict of Interest: None

Purpose: The aim of this study was to review the management of orbito-ocular malignancies in the Departments of Radiotherapy and Ophthalmology, Lagos University Teaching Hospital, between January 1997 and December 2011 in comparison to previous and recent studies globally.

Materials and Methods: This was a retrospective study of orbito-ocular malignancies seen at the Departments of Radiotherapy and Ophthalmology, Lagos University Teaching Hospital from 1997 to 2011. Case files and treatment cards were retrieved through the Medical Records department and the information required was extracted with the aid of a data extraction form.

Results: A total of 98 cases with histologically confirmed orbito-ocular malignancies seen during the 15-year study period were analysed. Retinoblastoma (51 [52.0%]) was the most common orbito-ocular malignancies seen in children, whereas squamous cell carcinoma of the conjunctiva (25 [25.5%]) was the most common in adults. Seventeen (17%) patients had a combination of radiotherapy, surgery, and chemotherapy. Thirty (33%) had enucleation, whereas 33 (36%) had exenteration. Thirty-six patients had chemotherapy, whereas 44 patients benefited from radiotherapy, and radical treatment was offered to 24 patients. Total radical treatment dose was 35–65 Gy in 20–35 fractions over 4–7 weeks. Most of the patients (84 [85.7%]) were lost to follow up. Five (5.1%) died from disease progression and four (4.1%) are still alive and on regular follow-up.

Conclusion: This study showed that the use of multimodality treatment was implemented but did not improve survival because the majority of patients presented late. The need for a collaborative effort in early detection and prompt referral for treatment of cancer cases cannot be overemphasised.